BACKGROUND: Hyponatraemia is the most frequent electrolyte disorder in hospitalized patients and has been associated with increased morbidity, mortality and length of hospital stay. There is evidence that also mild chronic hyponatraemia may have clinical consequences, such as gait disturbances, attention deficits, falls, increased risk of fractures and reduced bone mineral density. Nevertheless, this condition appears to be rather often not taken into consideration, or inappropriately managed and treated, thus negatively affecting patients' outcome. AIM: The aim of this study was to investigate the awareness and management of hyponatraemia secondary to SIAD, a common cause of hyponatraemia, among Italian physicians (endocrinologists, nephrologists, internists) commonly involved as consultants. METHODS: A questionnaire, covering definition, diagnosis, management, treatment and prognosis of hyponatraemia secondary to SIAD, was developed with the support of the Italian Society of Endocrinology. RESULTS: Among the respondents (n=275), the majority was aware of the negative implications of hyponatraemia or of an inappropriate treatment. Nevertheless, the answers indicated that SIAD is still underdiagnosed and incorrectly managed in clinical practice. In particular, only 47% of respondents used the validated biochemical parameters to diagnose hyponatraemia secondary to SIAD. The survey also indicated a rather satisfactory knowledge of the therapeutic options, including the currently available vasopressin receptor antagonists. CONCLUSIONS: One of the main findings of the survey was that the diagnostic work-up of hyponatraemia still represents a critical issue. Therefore, there is urgent need of educational programs in order to improve the management of this condition and reduce morbidity, mortality and costs.
BACKGROUND: Hyponatraemia is the most frequent electrolyte disorder in hospitalized patients and has been associated with increased morbidity, mortality and length of hospital stay. There is evidence that also mild chronic hyponatraemia may have clinical consequences, such as gait disturbances, attention deficits, falls, increased risk of fractures and reduced bone mineral density. Nevertheless, this condition appears to be rather often not taken into consideration, or inappropriately managed and treated, thus negatively affecting patients' outcome. AIM: The aim of this study was to investigate the awareness and management of hyponatraemia secondary to SIAD, a common cause of hyponatraemia, among Italian physicians (endocrinologists, nephrologists, internists) commonly involved as consultants. METHODS: A questionnaire, covering definition, diagnosis, management, treatment and prognosis of hyponatraemia secondary to SIAD, was developed with the support of the Italian Society of Endocrinology. RESULTS: Among the respondents (n=275), the majority was aware of the negative implications of hyponatraemia or of an inappropriate treatment. Nevertheless, the answers indicated that SIAD is still underdiagnosed and incorrectly managed in clinical practice. In particular, only 47% of respondents used the validated biochemical parameters to diagnose hyponatraemia secondary to SIAD. The survey also indicated a rather satisfactory knowledge of the therapeutic options, including the currently available vasopressin receptor antagonists. CONCLUSIONS: One of the main findings of the survey was that the diagnostic work-up of hyponatraemia still represents a critical issue. Therefore, there is urgent need of educational programs in order to improve the management of this condition and reduce morbidity, mortality and costs.
Authors: Mihai Gheorghiade; Stephen S Gottlieb; James E Udelson; Marvin A Konstam; Frank Czerwiec; John Ouyang; Cesare Orlandi Journal: Am J Cardiol Date: 2006-02-17 Impact factor: 2.778
Authors: Brian J Feldman; Stephen M Rosenthal; Gabriel A Vargas; Raymond G Fenwick; Eric A Huang; Mina Matsuda-Abedini; Robert H Lustig; Robert S Mathias; Anthony A Portale; Walter L Miller; Stephen E Gitelman Journal: N Engl J Med Date: 2005-05-05 Impact factor: 91.245
Authors: H Furst; K R Hallows; J Post; S Chen; W Kotzker; S Goldfarb; F N Ziyadeh; E G Neilson Journal: Am J Med Sci Date: 2000-04 Impact factor: 2.378
Authors: Sinead Kinsella; Sarah Moran; Miriam O Sullivan; Michael G M Molloy; Joseph A Eustace Journal: Clin J Am Soc Nephrol Date: 2010-01-07 Impact factor: 8.237
Authors: L Vannucci; G Parenti; G Simontacchi; G Rastrelli; C Giuliani; A Ognibene; A Peri Journal: J Endocrinol Invest Date: 2016-08-09 Impact factor: 4.256
Authors: Giovanni Corona; Corinna Giuliani; Joseph G Verbalis; Gianni Forti; Mario Maggi; Alessandro Peri Journal: PLoS One Date: 2015-04-23 Impact factor: 3.240
Authors: Giuseppe Vacchiano; Aldo Rocca; Rita Compagna; Anna Ginevra Immacolata Zamboli; Vera Cirillo; Lorenza Di Domenico; Veronica Di Nardo; Giuseppe Servillo; Bruno Amato Journal: Open Med (Wars) Date: 2017-03-31